Investment Analysts’ Price Target Changes for January 9th (ABVX, ALGT, ALK, APO, BAX, BX, CHH, CMG, COLL, CTEV)

Investment Analysts’ price target changes for Friday, January 9th:

Abivax (NASDAQ:ABVX) had its target price increased by Morgan Stanley from $101.00 to $145.00. They currently have an overweight rating on the stock.

Allegiant Travel (NASDAQ:ALGT) had its price target boosted by Susquehanna from $70.00 to $100.00. Susquehanna currently has a neutral rating on the stock.

Alaska Air Group (NYSE:ALK) had its price target raised by Susquehanna from $52.00 to $70.00. They currently have a positive rating on the stock.

Apollo Global Management (NYSE:APO) had its price target cut by Barclays PLC from $172.00 to $168.00. Barclays PLC currently has an overweight rating on the stock.

Baxter International (NYSE:BAX) had its target price cut by Barclays PLC from $36.00 to $30.00. They currently have an overweight rating on the stock.

Blackstone (NYSE:BX) had its target price cut by Barclays PLC from $172.00 to $171.00. Barclays PLC currently has an equal weight rating on the stock.

Choice Hotels International (NYSE:CHH) was given a $126.00 price target by analysts at Truist Financial Corporation. The firm currently has a buy rating on the stock.

Chipotle Mexican Grill (NYSE:CMG) had its target price boosted by Mizuho from $36.00 to $38.00. They currently have a neutral rating on the stock.

Collegium Pharmaceutical (NASDAQ:COLL) had its target price cut by Barclays PLC from $58.00 to $56.00. The firm currently has an overweight rating on the stock.

Claritev (NYSE:CTEV) had its price target reduced by Citigroup Inc. from $80.00 to $63.00. The firm currently has a buy rating on the stock.

Delta Air Lines (NYSE:DAL) had its target price raised by Susquehanna from $70.00 to $85.00. They currently have a positive rating on the stock.

DuPont de Nemours (NYSE:DD) had its target price increased by KeyCorp from $45.00 to $51.00. KeyCorp currently has an overweight rating on the stock.

Brinker International (NYSE:EAT) had its price target increased by Citigroup Inc. from $176.00 to $187.00. They currently have a buy rating on the stock.

Brinker International (NYSE:EAT) had its target price increased by Mizuho from $155.00 to $175.00. Mizuho currently has an outperform rating on the stock.

Evolent Health (NYSE:EVH) had its target price cut by Citigroup Inc. from $9.50 to $6.00. Citigroup Inc. currently has a buy rating on the stock.

GoodRx (NASDAQ:GDRX) had its price target reduced by Citigroup Inc. from $5.00 to $4.50. Citigroup Inc. currently has a buy rating on the stock.

Health Catalyst (NASDAQ:HCAT) had its price target trimmed by Citigroup Inc. from $3.25 to $2.75. They currently have a neutral rating on the stock.

JetBlue Airways (NASDAQ:JBLU) had its price target boosted by Susquehanna from $4.55 to $5.00. The firm currently has a neutral rating on the stock.

KalVista Pharmaceuticals (NASDAQ:KALV) had its price target increased by HC Wainwright from $27.00 to $37.00. They currently have a buy rating on the stock.

KKR & Co. Inc. (NYSE:KKR) had its target price reduced by Barclays PLC from $169.00 to $159.00. They currently have an overweight rating on the stock.

Life360 (NASDAQ:LIF) had its target price lowered by Citigroup Inc. from $96.80 to $79.50. Citigroup Inc. currently has a buy rating on the stock.

Southwest Airlines (NYSE:LUV) had its price target boosted by Susquehanna from $35.00 to $45.00. The firm currently has a neutral rating on the stock.

ServiceNow (NYSE:NOW) had its price target lowered by Stifel Nicolaus from $230.00 to $200.00. Stifel Nicolaus currently has a buy rating on the stock.

Phreesia (NYSE:PHR) had its price target trimmed by Citigroup Inc. from $29.00 to $25.00. They currently have a buy rating on the stock.

Phoenix Education Partners (NYSE:PXED) had its price target lowered by B. Riley from $60.00 to $54.00. The firm currently has a buy rating on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its price target increased by Needham & Company LLC from $40.00 to $42.00. The firm currently has a buy rating on the stock.

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target boosted by Needham & Company LLC from $145.00 to $148.00. Needham & Company LLC currently has a buy rating on the stock.

Seadrill (NYSE:SDRL) had its price target raised by BTIG Research from $33.00 to $40.00. The firm currently has a buy rating on the stock.

TD SYNNEX (NYSE:SNX) had its target price lowered by Morgan Stanley from $177.00 to $172.00. The firm currently has an overweight rating on the stock.

Spotify Technology (NYSE:SPOT) had its target price reduced by UBS Group AG from $850.00 to $800.00. They currently have a buy rating on the stock.

Teladoc Health (NYSE:TDOC) had its target price reduced by Citigroup Inc. from $10.00 to $9.00. Citigroup Inc. currently has a neutral rating on the stock.

United Airlines (NASDAQ:UAL) had its price target increased by Susquehanna from $117.00 to $150.00. They currently have a positive rating on the stock.

Frontier Group (NASDAQ:ULCC) had its target price boosted by Susquehanna from $4.00 to $5.00. They currently have a neutral rating on the stock.

Waystar (NASDAQ:WAY) had its target price reduced by Citigroup Inc. from $49.00 to $46.00. They currently have a buy rating on the stock.

Xenon Pharmaceuticals (NASDAQ:XENE) had its price target boosted by JPMorgan Chase & Co. from $60.00 to $62.00. They currently have an overweight rating on the stock.